Marcelo Kauffman, MD, PhD

Dr. Marcelo Kauffman is the Head of the Neurogenetics Unit at the Hospital JM Ramos Mejia, Buenos Aires, Argentina and the Precision Medicine and Clinical Genomics Program and Clinic at Austral University. He obtained his MD, MSc and PhD degrees from the University of Buenos Aires and from the University Pablo de Olavide in Spain. He completed his Residency in Neurology at the Hospital JM Ramos Mejia in Buenos Aires. He is researcher at the Argentine’s National Science Council (CONICET) and Assistant Professor of Neurology at the University of Buenos Aires, School of Medicine and Associate Professor of Clinical Genomics at Austral University. His clinical and research interests include the diagnosis, management and treatment of neurogenetic disorders. He has received many clinical and scientific awards and authored more than 40 peer-review papers, mainly in the field of neurogenetic diseases.

Finally, He is the Founder and CEO of Limay Biosciences, a new Biotech Start-Up that is developing the technologies needed for the new era of HyperLocal molecular testing.

Specialties: Clinical Neurology, Neurogenetics, Clinical Pharmacology, Biotechnology